Drug Profile
Sn-117m-DOTA-annexin V
Alternative Names: [Tin-117m]-DOTA-annexin V; Tin-AnnexinLatest Information Update: 22 Feb 2019
Price :
$50
*
At a glance
- Originator Clear Vascular
- Class Anti-inflammatories; Organometallic compounds; Radiopharmaceutical diagnostics; Radiopharmaceuticals
- Mechanism of Action Single-photon emission-computed tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Atherosclerosis
Most Recent Events
- 22 Feb 2019 Discontinued - Phase-II for Atherosclerosis (Diagnosis) in Chile (IV)
- 22 Feb 2019 Discontinued - Phase-II for Atherosclerosis in Chile (IV)
- 09 Feb 2016 Phase-II clinical trials in Atherosclerosis (Diagnosis) in Chile (IV) prior to February 2016